This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Neologics Bioscience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Haojie Wang - Innovator in Cancer Treatment
Introduction
Haojie Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. His innovative work has led to the development of important therapeutic agents.
Latest Patents
Haojie Wang holds a patent for TIM-3-targeting antibodies and their uses. This patent discloses anti-TIM-3 antibodies and antigen-binding fragments, along with polynucleotides encoding these antibodies. Additionally, it includes pharmaceutical compositions that comprise the antibodies and antigen-binding fragments. The patent also outlines the uses of these anti-TIM-3 antibodies in cancer treatment.
Career Highlights
Haojie Wang is associated with Suzhou Neologics Bioscience Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes through innovative therapies.
Collaborations
Haojie Wang collaborates with talented individuals such as Xin Dong and Jinyu Dong. Their combined expertise enhances the research and development initiatives at Suzhou Neologics Bioscience Co., Ltd.
Conclusion
Haojie Wang's contributions to cancer treatment through his patented innovations highlight his role as a leading inventor in the biotechnology field. His work continues to inspire advancements in therapeutic solutions for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile